Literature DB >> 2593730

Underutilization of antihypertensive drugs and associated hospitalization.

R F Maronde1, L S Chan, F J Larsen, L R Strandberg, M F Laventurier, S R Sullivan.   

Abstract

The association of underutilization of drugs prescribed for the treatment of hypertension and acute-care hospital readmissions was evaluated. The data base consisted of computerized hospitalization records and computerized out-patient pharmacy records, checked by chart audit for validity. The number of days' supply of antihypertensive agents was estimated by dividing the quantity of drugs dispensed by the daily dose indicated by the prescription instructions. All patients had been admitted to an acute-care hospital during a 6-month period with the diagnosis of hypertension. Following discharge from the hospital, drug utilization and readmission status were determined for a minimum of 1 year. The drug compliance of a group of patients who were readmitted to the hospital was compared with the patients who were not readmitted. The readmitted group had a significantly higher ratio of days when they were without any antihypertensive agents relative to the length of time in the study. There were no statistically significant differences in demographic features or blood-pressure levels between the patient groups. These findings indicate that underutilization of antihypertensive drugs may be associated with hospitalization, which could be prevented if patients had complied with their medication schedules.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2593730     DOI: 10.1097/00005650-198912000-00007

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  23 in total

Review 1.  Effect of partial compliance on cardiovascular medication effectiveness.

Authors:  Joyce A Cramer
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

2.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

3.  Teaching medication adherence in US colleges and schools of pharmacy.

Authors:  Nathaniel M Rickles; Linda Garrelts MacLean; Karl Hess; Kevin C Farmer; Afton M Yurkon; Carolyn C Ha; Emmanuelle Schwartzman; Anandi V Law; Paul A Milani; Katie Trotta; Sara R Labella; Rebecca J Designor
Journal:  Am J Pharm Educ       Date:  2012-06-18       Impact factor: 2.047

4.  Medication nonadherence and subsequent risk of hospitalisation and mortality among older adults.

Authors:  Shelly A Vik; David B Hogan; Scott B Patten; Jeffrey A Johnson; Lori Romonko-Slack; Colleen J Maxwell
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  The implications of noncompliance with antihypertensive medication.

Authors:  B Girvin; G D Johnston
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

6.  Partial compliance with antipsychotics increases mental health hospitalizations in schizophrenic patients: analysis of a national managed care database.

Authors:  Chris M Kozma; Peter J Weiden
Journal:  Am Health Drug Benefits       Date:  2009-01

7.  Compliance with medication among outpatients with uncontrolled hypertension in the Seychelles.

Authors:  P Hungerbuhler; P Bovet; C Shamlaye; B Burnand; B Waeber
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

8.  Hospital information system and patterns of cancer screening.

Authors:  K Nasseri; R Bastani; S Bernstein; L Breslow
Journal:  J Med Syst       Date:  1994-12       Impact factor: 4.460

Review 9.  Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection.

Authors:  Bernard Waeber; François Feihl; Luis M Ruilope
Journal:  Drugs       Date:  2009       Impact factor: 9.546

10.  Post-hospitalization followup appointment-keeping among the medically indigent.

Authors:  C I Kiefe; P L Harrison
Journal:  J Community Health       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.